$72.48
LGD 4033 + MK677 is offered in 2 variants: 20mg per tablet for 27 tablets, totaling 540mg and 20mg per tablet for 54 tablets, totaling 1080mg.
Ligandrol is a novel nonsteroidal oral selective androgen receptor modulator currently being investigated in research as a potential treatment for conditions relating to muscle dystrophy and osteoporosis. Studies have shown that Ligandrol may have benefits in increasing muscle mass and preventing bone loss. More extensive research and randomized trials could potentially evaluate its efficacy in improving physical function and health outcomes in select populations.
| LGD-4033 | |
| CAS Number | 1165910-22-4 |
| Molar Mass | 338.253 g·mol−1 |
| Chemical Formula | C14H12F6N2O |
| IUPAC Name | 4-[(2R)-2-[(1R)-2,2,2-trifluoro-1-hydroxyethyl]pyrrolidin-1-yl]-2-(trifluoromethyl)benzonitrile
|
| MK677 | |
| CAS Number | 159634-47-6 |
| Molar Mass | 528.67 g·mol−1 |
| Chemical Formula | C14H12F6N2O |
| IUPAC Name | 2-amino-2-methyl-N-[1-(1-methylsulfonylspiro[2H indole-3,4′-piperidine]-1′-yl)-1-oxo-3-phenylmethoxypropan-2-yl]propenamide |
onpeptides.com
